News and Announcements

Oxford Biomedica reiterates full-year guidance, flags first-half loss

By Abigail Townsend

Date: Thursday 26 Mar 2026

(Sharecast News) - Oxford Biomedica posted a surge in annual revenues on Thursday, but warned it was on track to swing to an interim loss this year before returning to growth in the second half.
The gene therapy specialist saw reported revenues climb 31% in the year to December end,to £168.7m,...

Sign up for free or to read the full story

Email this article to a friend

or share it with one of these popular networks:


Article Archive

Top of Page